Sanofi completes Merial stake buy from Merck
Sanofi-Aventis has completed the acquisitions of a 50 percent stake in animal health firm Merial from joint venture partner Merck & Co Inc for $4.0 billion in a deal that will be earnings enhancing from the first year.
Merial will report to Hanspeter Spek, Sanofi said on Friday.
(Reporting by Marcel Michelson)
© Copyright Thomson Reuters 2024. All rights reserved.
Join the Discussion
Editor's pick